In vitro biocompatibility evaluation of the dynamic bubble trap

Artificial Organs

Volumn 27, Issue 8, 2003, Pages 736-743

  Taborski, Uwe ^a,c   Urbanek, Petr ^b   Erhardt, Gunther ^a   Schönburg, Markus ^a   Basser, Svetlana ^a   Wohlgemuth, Larisa ^a   Heidinger, Kathrin ^a   Klövekorn, Wolf Peter ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b HPmedica   (Germany)

^c NONE   (Germany)

Author keywords

Air microbubbles; Biocompatibility; Cardiopulmonary bypass; Dynamic bubble trap; In vitro model

Indexed keywords

BLOOD; PHYSIOLOGICAL MODELS;

AIR MICROBUBBLE; BUBBLE-TRAP; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DYNAMIC BUBBLE TRAP; IN-VITRO; IN-VITRO MODELS; MICROBUBBLES; PHYSIOLOGICAL CONDITION; VITRO BIOCOMPATIBILITIES;

BIOCOMPATIBILITY;

COMPLEMENT COMPONENT C5A; CYTOKINE; D DIMER; HEMOGLOBIN; HEPARIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; PLACEBO; THROMBIN ANTITHROMBIN COMPLEX; TUMOR NECROSIS FACTOR ALPHA;

AIR; ARTICLE; BIOCOMPATIBILITY; BLOOD; BLOOD CLOTTING; BLOOD FLOW VELOCITY; BLOOD PUMP; BLOOD VISCOSITY; BLOOD VOLUME; CARDIOPULMONARY BYPASS; COMPLEMENT SYSTEM; CONTROLLED STUDY; DYNAMIC BUBBLE TRAP; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMODYNAMIC PARAMETERS; HEMOSTASIS; IMMUNE SYSTEM; IN VITRO STUDY; LEUKOCYTE; MATHEMATICAL MODEL; MODEL; OPEN HEART SURGERY; PRIORITY JOURNAL; TECHNOLOGY; THROMBOCYTE;

EID: 0042830781     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07143.x     Document Type: Article

References (18)

1. Kurusz M, Butler B, Katz J, Conti VR. Air embolism during cardiopulmonary bypass. Perfusion 1995;10:361-91.
2. Barbut D, Yao FS, Lo YW, Silverman R, Hager DN, Trifiletti RR, Gold JP. Determination of size of aortic emboli and embolic load during coronary artery bypass grafting. Ann Thorac Surg 1997;63:1262-7.
3. Deverall PB, Padayachee TS, Parsons S, Theobald R, Battistessa SA. Ultrasound detection of micro-emboli in the middle cerebral artery during cardiopulmonary bypass surgery. Eur J Cardiothorac Surg 1988;2:256-60.
4. Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ. Microemboli during coronary artery bypass grafting. J Thorac Cardiovasc Surg 1995;109:249-58.
5. Padayachee TS, Parsons S, Theobald R, Gosling RG, Deverall PB. The effect of arterial filtration on reduction of gaseous microemboli in the middle cerebral artery during cardiopulmonary bypass. Ann Thorac Surg 1988;45:647-9.
6. Taylor RL, Bogert AM, Weisel RD, Fedorko L, Feindel CM. Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist intervention. Ann Thorac Surg 1999;68:89-93.
7. Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham SH, Ley C. Adverse cerebral outcome after coronary bypass surgery. N Engl J Med 1996;335:1857-63.
8. Walzer T, Herrmann M, Wallesch CW. Neuropsychological disorders after coronary bypass surgery. J Neurol Neurosurg Psychiatry 1997;62:644-8.
9. Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 1994;25:1393-9.
10. Van Dijk D, Keizer AMA, Diephuis JC, Durand C, Vos LJ, Hijman R. Neurocognitive dysfunction after coronary artery bypass surgery: A systemic review. J Thorac Cardiovasc Surg 2000;120:632-9.
11. nd Edition. New York: McGraw-Hill, 1971.
12. Mellgren K, Skogby M, Jarnas A, Friberg LG, Wadenvik H, Mellgren G. Platelet activation and degradation in an experimental extracorporeal system. A comparison between a silicone membrane and a hollow-fibre oxygenator. Perfusion 1996;11:383-8.
13. Gencbay M, Degertekin M, Basaran Y, Yaymaci B, Izgi A, Dindar I, Turan F. Microbubbles associated with mechanical heart valves: their relation with serum lactic dehydrogenase levels. Am Heart J 1999;137:463-8.
14. Watanabe H, Hayashi J. Ohzeki H, Moro H, Sugawara S, Eguchi S. Biocompatibility of a silicone-coated polypropylene hollow fiber oxygenator in an in vitro model. Ann Thorac Surg 1999;67:1315-9.
15. Nishida H, Aomi S, Tomizawa Y, Endo M, Koyanagi H, Nojiri C, Oshiyama H, Kido T, Yokoyama K. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass. Artif Organs 1999;23:547-51.
16. Urlesberger B, Zobel G, Rodl S, Dacar D, Friehs I, Leschnik B, Muntean W. Activation of the clotting system: heparin-coated versus non-coated systems for extracorporeal circulation. Int J Artif Organs 1997;20:708-12.
17. Mollnes TE, Videm V, Gotze O, Harboe M, Oppermann M. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. Ann Thorac Surg 1991;52:92-7.
18. Adrian K, Mellgren K, Skogby M, Friberg LG, Mellgren G, Wadenvik H. Cytokine release during long-term extracorporeal circulation in an experimental model. Artif Organs 1998;22:859-63.